Aquaporin's First Quarter Update: Strong Financial Resilience
Aquaporin A/S Announces Q1 2025 Trading Statement
Company Announcement
No. 08/2025
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Aquaporin A/S (CSE: AQP) is an innovative company rethinking water filtration technologies using biotechnology. The Company has released its Q1 2025 Trading Statement, detailing its financial performance for the period covering January to March 2025.
In a statement, Matt Boczkowski, the Chief Executive Officer of Aquaporin, expressed optimism about the future, saying, "We expect to be back on our previous growth track as we advance on our journey towards profitability. The commercial traction is resuming, and we have a growing inflow of orders that will materialize throughout the year."
Klaus Juhl Wulff, the Chief Financial Officer, reaffirmed the Company’s financial guidance, noting, "As in previous years, we expect revenue to be backend loaded towards the second half of 2025. Our orderbook and pipeline have matured positively year-to-date, and we are reaffirming the communicated financial guidance for the year." The guidance includes projected revenue of DKK 60-80 million and an EBITDA loss of DKK 45-55 million.
Financial Highlights for Q1 2025
The Company highlighted several financial metrics as of March 31, 2025:
- Revenue for Q1 2025 was DKK 3.2 million, down from DKK 6.2 million during the same period in 2024, largely driven by developments in the Forward Osmosis Market.
- EBITDA loss stood at DKK 15.3 million, showing improvement from a DKK 19.3 million loss in Q1 of the previous year.
- Cash and cash equivalents improved significantly to DKK 58.5 million compared to DKK 2.0 million in the first quarter of 2024.
Business Highlights
Several key business developments were noted within the quarter:
- Aquaporin's focus on strategic accounts has begun to yield results, as evidenced by repeat orders from a diverse customer base.
- Collaboration with Gallo has also progressed, marked by exceptional concentration quality levels achieved at pilot-scale tests.
- A significant agreement was signed with Liaocheng Water Group as part of the Sino-Danish Water Alliance. This partnership aims to enhance industrial wastewater treatment processes in collaboration with companies like Grundfos and DHI.
Future Developments and Operations
Aquaporin is dedicated to expanding its influence in global water technology innovations. In South America, the Company strengthened its market presence through new orders from system integrator VOENS, utilizing the CLEAR Series technology for effective wastewater recycling. Moreover, Aquaporin has secured contracts in Ireland to implement Forward Osmosis systems, facilitating groundbreaking developments in bio-based product recovery.
The Company has also shipped 500 CLEAR membranes to a partnering organization based in Beijing to enhance energy efficiency in their operations. Successful trials in collaboration with Singapore's National Water Agency affirm the viability of Aquaporin's technologies.
Leadership Transition
In April, it was announced that CEO Matt Boczkowski will transition out of his role by September 2025. The Board of Directors is initiating a search for a new leader, ensuring a smooth transition to uphold the Company's operational integrity and continued growth in its innovative ventures.
Conclusion and Outlook
For the outset of 2025, Aquaporin's capabilities in both Forward Osmosis and Reverse Osmosis have proven effective. With a robust orderbook and pipeline in place, the Company remains optimistic about achieving its financial targets for the year. The expectation is that significant revenue improvement will manifest in the latter half of the year, aligning with the established growth trajectory. As new partnerships emerge and existing collaborations deepen, Aquaporin is well-positioned to showcase sustainable solutions worldwide.
Frequently Asked Questions
What were Aquaporin's Q1 2025 revenues?
Aquaporin reported revenues of DKK 3.2 million for Q1 2025.
How has EBITDA changed year-over-year?
EBITDA improved to a loss of DKK 15.3 million in Q1 2025, compared to a loss of DKK 19.3 million in the same quarter of 2024.
What financial guidance has Aquaporin provided for 2025?
The Company maintains a financial guidance of DKK 60-80 million in revenue, expecting a loss of DKK 45-55 million in EBITDA for the full year.
Is Aquaporin expanding its market presence?
Yes, Aquaporin is strengthening its presence in various regions, particularly in South America and expanding its collaborations globally.
Who will succeed Matt Boczkowski as CEO?
The search for a new CEO is being conducted by the Board of Directors following Matt Boczkowski's planned departure by September 2025.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to [email protected].
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.